1. Home
  2. LCFY vs MBIO Comparison

LCFY vs MBIO Comparison

Compare LCFY & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Locafy Limited

LCFY

Locafy Limited

HOLD

Current Price

$3.12

Market Cap

9.2M

Sector

N/A

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$1.02

Market Cap

4.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCFY
MBIO
Founded
2009
2015
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
4.7M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
LCFY
MBIO
Price
$3.12
$1.02
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.9K
91.9K
Earning Date
03-13-2026
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,099,713.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.51
$0.89
52 Week High
$13.98
$21.95

Technical Indicators

Market Signals
Indicator
LCFY
MBIO
Relative Strength Index (RSI) 33.91 34.37
Support Level $3.01 $1.05
Resistance Level $3.98 $1.14
Average True Range (ATR) 0.20 0.07
MACD -0.03 -0.01
Stochastic Oscillator 19.37 9.37

Price Performance

Historical Comparison
LCFY
MBIO

About LCFY Locafy Limited

Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: